Laxmi Dental IPO is a book built issue of Rs 698.06 crores. The issue is a combination of fresh issue of 0.32 crore shares aggregating to Rs 138.00 crores and offer for sale of 1.31 crore shares aggregating to Rs 560.06 crores.
Laxmi Dental IPO opens for subscription on January 13, 2025 and closes on January 15, 2025. The allotment for the Laxmi Dental IPO is expected to be finalized on Thursday, January 16, 2025. Laxmi Dental IPO will list on BSE, NSE with tentative listing date fixed as Monday, January 20, 2025.
Laxmi Dental IPO price band is set at ₹407 to ₹428 per share. The minimum lot size for an application is 33. The minimum amount of investment required by retail investors is ₹14,124. The minimum lot size investment for SNII is 15 lots (495 shares), amounting to ₹2,11,860, and for BNII, it is 71 lots (2,343 shares), amounting to ₹10,02,804.
Laxmi Dental IPO Timeline
Laxmi Dental IPO opens on January 13, 2025, and closes on January 15, 2025.
| IPO Open Date | Monday, January 13, 2025 |
| IPO Close Date | Wednesday, January 15, 2025 |
| Basis of Allotment | Thursday, January 16, 2025 |
| Initiation of Refunds | Friday, January 17, 2025 |
| Credit of Shares to Demat | Friday, January 17, 2025 |
| Listing Date | Monday, January 20, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on January 15, 2025 |
Laxmi Dental IPO Details
| IPO Date | January 13, 2025 to January 15, 2025 |
| Listing Date | [.] |
| Face Value | ₹2 per share |
| Price Band | ₹407 to ₹428 per share |
| Lot Size | 33 Shares |
| Total Issue Size | 1,63,09,766 shares (aggregating up to ₹698.06 Cr) |
| Fresh Issue | 32,24,299 shares (aggregating up to ₹ 138.00 Cr) |
| Offer for Sale | 1,30,85,467 shares of ₹2 (aggregating up to ₹560.06 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 5,17,37,850 shares |
| Share Holding Post Issue | 5,49,62,149 shares |
About Laxmi Dental Limited
Incorporated in July 2004, Laxmi Dental Limited is an integrated dental products company. The company offers custom crowns and bridges, branded dental items like clear aligners and thermoforming sheets, aligner-related products as part of its aligner solutions, and pediatric dental products.
Their product portfolio includes custom crowns and bridges, clear aligners, thermoforming sheets, pediatric dental products, and more.
The company offers thermoforming sheets, biocompatible 3D printing resins, and machines for manufacturing clear aligners under the brand name Taglus.
The company operate a fully integrated model, meaning they handle the entire process from design and manufacturing to distribution of dental products.
As of September 30, 2024, The company has six manufacturing facilities: 3rd in Mira Road, Mumbai, 2nd in Boisar, and 1st in Kochi, along with five supporting facilities in Mumbai, Delhi, Bengaluru, and Ahmedabad.
Objects of the Issu
Objects of the Fresh Issue Our Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company.
- Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings.
- Funding the capital expenditure requirements for purchasing new machinery for the Company.
- Investment in our subsidiary, Bizdent Devices Private Limited, is needed for the capital expenditure requirements for the purchase of new machinery.
- General corporate purposes.
Continuing the trend from the previous calendar year, 2025 is poised for a surge in initial public offerings (IPOs) with nearly ₹1.8 lakh crore worth of issues already pending Securities and Exchange Board of India (SEBI) approval.
The report, citing data from Prime Database, noted that the IPO pipeline this year includes 28 companies aiming to raise ₹46,000 crore. Additionally, more than 80 companies, looking to raise ₹1.32 lakh crore, are awaiting a nod from the SEBI.